Impact of diabetes status on immunogenicity of trivalent inactivated influenza vaccine in older adults

被引：4
|
作者：
Spencer, Sarah [1 ]
Chung, Jessie R. [1 ]
Belongia, Edward A. [2 ]
Sundaram, Maria [2 ]
Meece, Jennifer [2 ]
Coleman, Laura A. [2 ,3 ]
Zimmerman, Richard K. [4 ]
Nowalk, Mary Patricia [4 ]
Geffel, Krissy Moehling [4 ]
Ross, Ted [4 ,5 ]
Carter, Chalise E. [4 ,5 ]
Shay, David [1 ]
Levine, Min [1 ]
Liepkalns, Justine [1 ,6 ]
Kim, Jin Hyang [1 ,7 ]
Sambhara, Suryaprakash [1 ]
Thompson, Mark G. [1 ]
Flannery, Brendan [1 ]
机构：
[1] US Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30333 USA
[2] Novartis Inst Biomed Res, Translat Med, Basel, Switzerland
[3] Marshfield Clin Res Inst, Ctr Clin Epidemiol & Populat Hlth, Marshfield, WI USA
[4] Univ Georgia, Dept Infect Dis, Ctr Vaccines & Immunol, Athens, GA 30602 USA
[5] Univ Pittsburgh, Sch Med, Dept Family Med, Pittsburgh, PA USA
[6] Univ Washington, Dept Biol, Seattle, WA 98195 USA
[7] Bristol Myers Squibb, Translat Med, Princeton, NJ USA
来源：
INFLUENZA AND OTHER RESPIRATORY VIRUSES | 2022年 / 16卷 / 03期
基金：
美国国家卫生研究院;
关键词：
influenza; serologic response; vaccine; SEASONAL INFLUENZA; ANTIBODY-RESPONSE; EFFICACY; TITERS;
D O I：
10.1111/irv.12933
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Individuals with type 2 diabetes mellitus experience high rates of influenza virus infection and complications. We compared the magnitude and duration of serologic response to trivalent influenza vaccine in adults aged 50-80 with and without type 2 diabetes mellitus. Serologic response to influenza vaccination was similar in both groups: greater fold-increases in antibody titer occurred among participants with lower pre-vaccination antibody titers. Waning of antibody titers was not influenced by diabetes status.
引用
收藏
页码：562 / 567
页数：6
相关论文
共 50 条
  • [1] Immunogenicity and safety of a trivalent inactivated influenza vaccine
    Fadlyana, Eddy
    Rusmili, Kusnandi
    Bachtiar, Novilia Sjafri
    Gunadi, Rachmat
    Sukandar, Hadyana
    [J]. PAEDIATRICA INDONESIANA, 2011, 51 (01) : 22 - 28
  • [2] Safety and immunogenicity of a quadrivalent inactivated influenza vaccine compared to licensed trivalent inactivated influenza vaccines in adults
    Greenberg, David P.
    Robertson, Corwin A.
    Noss, Michael J.
    Blatter, Mark M.
    Biedenbender, Rex
    Decker, Michael D.
    [J]. VACCINE, 2013, 31 (05) : 770 - 776
  • [3] Safety and immunogenicity of trivalent inactivated influenza vaccine in infants
    Halasa, Natasha B.
    Gerber, Michael A.
    Chen, Qingxia
    Wright, Peter F.
    Edwards, Kathryn M.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2008, 197 (10): : 1448 - 1454
  • [4] Safety and immunogenicity of a Proteosome™-trivalent inactivated influenza vaccine, given nasally to healthy adults
    Langley, JM
    Halperin, SA
    McNeil, S
    Smith, B
    Jones, T
    Burt, D
    Mallett, CP
    Lowell, GH
    Fries, L
    [J]. VACCINE, 2006, 24 (10) : 1601 - 1608
  • [5] Immunogenicity, safety and consistency of new trivalent inactivated influenza vaccine
    Talbot, H. Keipp
    Keitel, Wendy
    Cate, Thomas R.
    Treanor, John
    Campbell, James
    Bradye, Rebecca C.
    Graham, Irene
    Dekker, Cornelia L.
    Ho, Dora
    Winokur, Patricia
    Walter, Emmanuel
    Bennet, Jillian
    Formica, Neil
    Hartel, Gunter
    Skeljo, Maryanne
    Edwards, Kathryn M.
    [J]. VACCINE, 2008, 26 (32) : 4057 - 4061
  • [6] Immunogenicity and safety of quadrivalent versus trivalent inactivated influenza vaccine: a randomized, controlled trial in adults
    Beran, Jiri
    Peeters, Mathieu
    Dewe, Walthere
    Raupachova, Jolana
    Hobzova, Lenka
    Devaster, Jeanne-Marie
    [J]. BMC INFECTIOUS DISEASES, 2013, 13
  • [7] Immunogenicity and safety of quadrivalent versus trivalent inactivated influenza vaccine: a randomized, controlled trial in adults
    Jiří Beran
    Mathieu Peeters
    Walthère Dewé
    Jolana Raupachová
    Lenka Hobzová
    Jeanne-Marie Devaster
    [J]. BMC Infectious Diseases, 13
  • [8] Safety and Immunogenicity of Bivalent RSVpreF Vaccine Coadministered With Seasonal Inactivated Influenza Vaccine in Older Adults
    Athan, Eugene
    Baber, James
    Quan, Karen
    Scott, Robert J.
    Jaques, Anna
    Jiang, Qin
    Li, Wen
    Cooper, David
    Cutler, Mark W.
    Kalinina, Elena, V
    Anderson, Annaliesa S.
    Swanson, Kena A.
    Gruber, William C.
    Gurtman, Alejandra
    Schmoele-Thoma, Beate
    [J]. CLINICAL INFECTIOUS DISEASES, 2024, 78 (05) : 1360 - 1368
  • [9] Immunogenicity and safety of a trivalent inactivated influenza vaccine produced in Shenzhen, China
    Mo, Zhaojun
    Nong, Yi
    Liu, Shuzhen
    Shao, Ming
    Liao, Xueyan
    Go, Kerry
    Lavis, Nathalie
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2017, 13 (06) : 1272 - 1278
  • [10] Impact of vitamin D administration on immunogenicity of trivalent inactivated influenza vaccine in previously unvaccinated children
    Principi, Nicola
    Marchisio, Paola
    Terranova, Leonardo
    Zampiero, Alberto
    Baggi, Elena
    Daleno, Cristina
    Tirelli, Silvia
    Pelucchi, Claudio
    Esposito, Susanna
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2013, 9 (05) : 969 - 974
12345